Engineering Entrance Exams Interview Preparation Guide
Sharpen your Engineering Entrance Exams interview expertise with our handpicked 15 questions. These questions are specifically selected to challenge and enhance your knowledge in Engineering Entrance Exams. Perfect for all proficiency levels, they are key to your interview success. Access the free PDF to get all 15 questions and give yourself the best chance of acing your Engineering Entrance Exams interview. This resource is perfect for thorough preparation and confidence building.15 Engineering Entrance Exams Questions and Answers:
1 :: What is the name of transformer?
Transformer name always in KVA rating .
It has constant value of power internally. Don't change of its power at any working condition.
It has constant value of power internally. Don't change of its power at any working condition.
2 :: You drive A car is KA17 M8719.it leaves at10.26 am from hyderbad to banglore which is 264 km away at a speed 85km/hr &reaches at 4.14.Now tell me What is the date of birthday of driver?
it is known that there is no information of the driver so
there is no anwer for this
there is no anwer for this
3 :: In c#, a statement "a?b:c" means?
a = answer b if not null else c
4 :: A new group of countries called BASIC is frequently mentioned in the news. which of the following is not one of them?
(a) Argentina (b) Brazil (c) India (d) South Africa?
(a) argentina
because The first official meeting of the BASIC group of
countries (China, India, Brazil, South Africa) concluded in
New Delhi. The meeting underlined that this new negotiating
group is here to stay and likely to be pivotal in shaping
future international climate talks. The Group, which played
a central role in negotiating last month's 'Copenhagen
Accord', set out a range of positions in a joint statement.
because The first official meeting of the BASIC group of
countries (China, India, Brazil, South Africa) concluded in
New Delhi. The meeting underlined that this new negotiating
group is here to stay and likely to be pivotal in shaping
future international climate talks. The Group, which played
a central role in negotiating last month's 'Copenhagen
Accord', set out a range of positions in a joint statement.
5 :: Which one of the following Union Ministries launched the
Eco-Mark scheme for labeling the consumer products?
(1) Ministry of Agro and Rural Industries
(2) Ministry of Environment and Forests
(3) Ministry of Food Processing Industries
(4) Ministry of Consumer Affairs, Food and Public Distribution.
(4) Ministry of Consumer Affairs, Food and Public Distribution.
6 :: ARTASSIST DEVICE FOR TRATING DIABETIC FOOT ULCER .CLADICATION, VASCULARSTENOSIS
Diabetes is the most frequent cause of non-traumatic lower
limb amputation, with more than 92,000 amputations
performed each year, according to the American Diabetes
Association. Diabetic foot ulcers, suffered by more than
two million diabetics annually, commonly result from
reduced blood flow and can lead to amputation. Direct costs
of a major amputation are estimated to be between $20,000
and $60,000. In contrast, the ArtAssist device can help
people avoid the prospect of disabling amputation and only
rents for $1,200 for a 3-month course of therapy.
"In our clinical study, the ArtAssist device significantly
increased blood flow and saved limbs in 70 percent of the
patients studied," said Dr. Paul S. van Bemmelen, vascular
surgeon at Stony Brook University Hospital, New York
. "We must get the word out now to help prevent amputation
in as many people as possible."
By increasing blood flow, the ArtAssist device also
relieves symptoms of peripheral arterial disease, also
known as "hardening of the arteries," which affects more
than four million Americans each year, the majority of whom
are over the age of 55. Symptoms, called intermittent
claudication
, include pain, cramps or a tired-feeling in the calf or
thigh, triggered by walking and relieved by rest. This
prevents the ability to walk and greatly reduces the
quality of life. Clinical studies have shown that the
ArtAssist device triples blood flow and dramatically
increases pain-free walking distance.
The ArtAssist device applies a massage-like compression to
enhance blood flow and simulates the beneficial effect of
brisk walking, without pain or tissue trauma. Patients
simply turn the device on after applying the specially
designed limb cuffs. The standard therapy calls for
patients to use the ArtAssist device for three hours a day
in one-hour segments and beneficial results appear within
days to weeks, with more permanent results achieved in
three to five months.
Poor blood flow from diabetes had already cost Frank
Berhalter of Long Island his right leg. But by using the
ArtAssist device to improve his circulation, Berhalter has
been able to keep his other leg and enjoy an independent
lifestyle.
"I started using the ArtAssist device for a diabetic foot
ulcer that was not healing," said Berhalter. "This was the
same symptom that led to the amputation of my right leg and
so I was very concerned. The ArtAssist device was simple to
use and after three months, my ulcer was completely healed.
I credit ArtAssist for saving my leg."
Currently not covered by Medicare/Medicaid, ACI Medical is
in the process of obtaining an individual Medicare/Medicaid
code for the ArtAssist device. Many private insurance
carriers cover the device as Durable Medical Equipment
.
"We originally developed this technology to assist in
imaging vessels in the foot," said Ed Arkans, president of
ACI Medical. "After testing the device in a hospital
setting, we were surprised to see a large increase in
arterial blood
flow and the immediate alleviation of pain in a patient
with severe arterial disease. We then decided to develop a
product based on this technology to hopefully save patients
the trauma of amputation."
About ACI Medical
Headquartered in San Marcos, ACI Medical designs and
manufactures products for vascular disease. More than 25
clinical studies by vascular surgeons at university-based
hospitals have been published or presented at medical
conferences, and confirm that use of the ArtAssist device
has significant effect on improving blood flow in patients
unable to undergo surgery and has the potential to reduce
the need for amputation by more than 50 percent. Abstracts
and further information are available on the ACI Medical
limb amputation, with more than 92,000 amputations
performed each year, according to the American Diabetes
Association. Diabetic foot ulcers, suffered by more than
two million diabetics annually, commonly result from
reduced blood flow and can lead to amputation. Direct costs
of a major amputation are estimated to be between $20,000
and $60,000. In contrast, the ArtAssist device can help
people avoid the prospect of disabling amputation and only
rents for $1,200 for a 3-month course of therapy.
"In our clinical study, the ArtAssist device significantly
increased blood flow and saved limbs in 70 percent of the
patients studied," said Dr. Paul S. van Bemmelen, vascular
surgeon at Stony Brook University Hospital, New York
. "We must get the word out now to help prevent amputation
in as many people as possible."
By increasing blood flow, the ArtAssist device also
relieves symptoms of peripheral arterial disease, also
known as "hardening of the arteries," which affects more
than four million Americans each year, the majority of whom
are over the age of 55. Symptoms, called intermittent
claudication
, include pain, cramps or a tired-feeling in the calf or
thigh, triggered by walking and relieved by rest. This
prevents the ability to walk and greatly reduces the
quality of life. Clinical studies have shown that the
ArtAssist device triples blood flow and dramatically
increases pain-free walking distance.
The ArtAssist device applies a massage-like compression to
enhance blood flow and simulates the beneficial effect of
brisk walking, without pain or tissue trauma. Patients
simply turn the device on after applying the specially
designed limb cuffs. The standard therapy calls for
patients to use the ArtAssist device for three hours a day
in one-hour segments and beneficial results appear within
days to weeks, with more permanent results achieved in
three to five months.
Poor blood flow from diabetes had already cost Frank
Berhalter of Long Island his right leg. But by using the
ArtAssist device to improve his circulation, Berhalter has
been able to keep his other leg and enjoy an independent
lifestyle.
"I started using the ArtAssist device for a diabetic foot
ulcer that was not healing," said Berhalter. "This was the
same symptom that led to the amputation of my right leg and
so I was very concerned. The ArtAssist device was simple to
use and after three months, my ulcer was completely healed.
I credit ArtAssist for saving my leg."
Currently not covered by Medicare/Medicaid, ACI Medical is
in the process of obtaining an individual Medicare/Medicaid
code for the ArtAssist device. Many private insurance
carriers cover the device as Durable Medical Equipment
.
"We originally developed this technology to assist in
imaging vessels in the foot," said Ed Arkans, president of
ACI Medical. "After testing the device in a hospital
setting, we were surprised to see a large increase in
arterial blood
flow and the immediate alleviation of pain in a patient
with severe arterial disease. We then decided to develop a
product based on this technology to hopefully save patients
the trauma of amputation."
About ACI Medical
Headquartered in San Marcos, ACI Medical designs and
manufactures products for vascular disease. More than 25
clinical studies by vascular surgeons at university-based
hospitals have been published or presented at medical
conferences, and confirm that use of the ArtAssist device
has significant effect on improving blood flow in patients
unable to undergo surgery and has the potential to reduce
the need for amputation by more than 50 percent. Abstracts
and further information are available on the ACI Medical
7 :: Why 6.6kw motor star connectet delta not connected
both candition is star and delta.
8 :: How a student should prepare for gate exams
read the basics of engneering subjects clearly....
also read the quantitative aptitude thoroughly
also read the quantitative aptitude thoroughly
9 :: What is the common name of cis- dichloro Dicyano platinate?
cis-platin
10 :: I wrote letters to four different people and wrote their addresses on four envelopes. But while inserting each letter into an envelope. I was careless. Either I put three letters in right envelopes, or I put two letters in right envelopes or I put one letter in wrong envelope, what did I do?
you put 2 letters in the right envelope and 2 in the wrong
as it is not possible to put 3 right letters or 1 wrong
letter because if 3 letters are put correctly then the
fourth one has to be in the right envelope
as it is not possible to put 3 right letters or 1 wrong
letter because if 3 letters are put correctly then the
fourth one has to be in the right envelope